Argent BioPharma Limited (H5O0.F)
These figures are from 2024-06-30.
Nothing newer has been filed in the 28 months since.
Argent BioPharma Limited reported revenue of 891.1K AUD for the year ending 30 June 2024, down 73.7% from 3.4M a year earlier.
Every figure below is the company's own, as filed. Nothing is estimated and
nothing is smoothed — a period the filing does not support is left blank rather than
filled in.
Quarters are the company's own, counted from its financial
year ending 06-30.
Amounts in AUD.
The same series drawn ›
As last reported
The newest period the filing supports for each figure, in AUD.
| Figure | Period | Amount | Year on year |
|---|
| Revenue |
2024 · ending 30 June 2024 |
891.1K |
-73.7% |
| Gross Profit |
2024 · ending 30 June 2024 |
203.7K |
-86.0% |
| Operating Income |
2024 · ending 30 June 2024 |
-16.7M |
— |
| Net Income |
2024 · ending 30 June 2024 |
-17.5M |
— |
| Cost of Revenue |
2024 · ending 30 June 2024 |
687.4K |
-64.5% |
| Operating Cash Flow |
2024 · ending 30 June 2024 |
-14.7M |
— |
| Free Cash Flow |
2024 · ending 30 June 2024 |
-14.8M |
— |
Revenue and profit by financial year
As filed, in AUD. A year the filing does not support is not listed.
| Year | Ending |
Revenue | Operating Income | Net Income | Free Cash Flow |
|---|
| 2024 | 2024-06-30 |
891.1K | -16.7M | -17.5M | -14.8M |
|---|
| 2023 | 2023-06-30 |
3.4M | -19.9M | -21.1M | -12.2M |
|---|
| 2022 | 2022-06-30 |
4.7M | -20.6M | -20.8M | -14.9M |
|---|
Every period
Revenue Annual
| Period | Ending | Revenue |
|---|
| FY24 | 2024-06-30 | 891.1K |
|---|
| FY23 | 2023-06-30 | 3.4M |
|---|
| FY22 | 2022-06-30 | 4.7M |
|---|
Gross Profit Annual
| Period | Ending | Gross Profit |
|---|
| FY24 | 2024-06-30 | 203.7K |
|---|
| FY23 | 2023-06-30 | 1.5M |
|---|
| FY22 | 2022-06-30 | 1.8M |
|---|
Operating Income Annual
| Period | Ending | Operating Income |
|---|
| FY24 | 2024-06-30 | -16.7M |
|---|
| FY23 | 2023-06-30 | -19.9M |
|---|
| FY22 | 2022-06-30 | -20.6M |
|---|
Net Income Annual
| Period | Ending | Net Income |
|---|
| FY24 | 2024-06-30 | -17.5M |
|---|
| FY23 | 2023-06-30 | -21.1M |
|---|
| FY22 | 2022-06-30 | -20.8M |
|---|
Cost of Revenue Annual
| Period | Ending | Cost of Revenue |
|---|
| FY24 | 2024-06-30 | 687.4K |
|---|
| FY23 | 2023-06-30 | 1.9M |
|---|
| FY22 | 2022-06-30 | 2.9M |
|---|
Operating Cash Flow Annual
| Period | Ending | Operating Cash Flow |
|---|
| FY24 | 2024-06-30 | -14.7M |
|---|
| FY23 | 2023-06-30 | -12M |
|---|
| FY22 | 2022-06-30 | -12.2M |
|---|
Free Cash Flow Annual
Operating cash flow minus capital expenditure.
| Period | Ending | Free Cash Flow |
|---|
| FY24 | 2024-06-30 | -14.8M |
|---|
| FY23 | 2023-06-30 | -12.2M |
|---|
| FY22 | 2022-06-30 | -14.9M |
|---|